Hyperresponsiveness, resistance to B-cell receptor - Dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes

Diabetes

Volumn 53, Issue 8, 2004, Pages 2003-2011

  Hussain, Shabbir ^a   Salojin, Konstantin V ^a   Delovitch, Terry L ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; INTERLEUKIN 4;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL CYCLE S PHASE; CELL DIVISION; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPLEEN;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL CYCLE; CELL DIVISION; DIABETES MELLITUS, TYPE 1; ISLETS OF LANGERHANS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; RECEPTORS, ANTIGEN, B-CELL; SPLEEN;

EID: 3242756636     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.8.2003     Document Type: Article

References (41)

1. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D: Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A 93:2260-2263, 1996
2. Delovitch TL, Singh B: The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727-738, 1997
3. Lanzavecchia A: Antigen uptake and accumulation in antigen-specific B cells. Immunol Rev 99:39-51, 1987
4. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A: B cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46:941-946, 1997
5. Akashi T, Nagafuchi S, Anzai K, Kondo S, Kitamura D, Wakana S, Ono J, Kikuchi M, Niho Y, Watanabe T: Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol 9:1159-1164, 1997
6. Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N: B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 161:1163-1168, 1998.
7. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM: B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161:3912-3918, 1998
8. Noorchashm H, Moore DJ, Noto LE, Noorchashm N, Reed AJ, Reed AL, Song HK, Mozaffari R, Jevnikar AM, Barker CF, Naji A: Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol 165:4685-4696, 2000
9. Greeley SA, Moore DJ, Noorchashm H, Noto LE, Rostami SY, Schlachterman A, Song HK, Koeberlein B, Barker CF, Naji A. Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol 167:4351-4357, 2001
10. Batista FD, Iber D, Neuberger MS: B cells acquire antigen from target cells after synapse formation. Nature 411:489-494, 2001
11. Chiu PP, Jevnikar AM, Danska JS: Genetic control of T and B lymphocyte activation in nonobese diabetic mice. J Immunol 167:7169-7179, 2001
12. Rathmell JC, Fournier S, Weintraub BC, Allison JP, Goodnow CC: Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells. J Exp Med 188:651-659, 1998
13. Mecklenbrauker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A: Protein kinase Cdelta controls self-antigen-induced B cell tolerance. Nature 416:860-865, 2002
14. Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, Nakayama KI: Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416:865-869, 2002
15. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC: Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765-769, 1991
16. King LB, Norvell A, Monroe JG: Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells. J Immunol 162:2655-2662, 1999
17. Sandel PC, Monroe JG: Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 10:289-299, 1999
18. Kozono Y, Kotzin BL, Holers VM: Resting B cells from New Zealand black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J Immunol 156:4498-4503, 1996
19. Parry SL, Hasbold J, Holman M, Klaus GG: Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 152:2821-2829, 1994
20. Sater RA, Sandel PC, Monroe JG: B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 10:1673-1682, 1998
21. Tian MT, Chou CH, DeFranco AL: Apoptosis induced by the antigen receptor and Fas in a variant of the immature B cell line WEHI-231 and in splenic immature B cells. Int Immunol 13:581-592, 2001
22. Tsubata T, Wu J, Honjo T: B-cell apoptosis induced by antigen receptor cross-linking is blocked by a T-cell signal through CD40. Nature 364:645-648, 1993
23. Kozono Y, Duke RC, Schleicher MS, Holers VM: Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur J Immunol 25:1013-1017, 1995
24. Prochazka M, Serreze DV, Frankel WN, Leiter EH: NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41:98-106, 1992
25. Abiru N, Yu L, Miao D, Maniatis AK, Liu E, Moriyama H, Eisenbarth GS: Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains. J Autoimmun 17:1-6, 2001
26. Grattan M, Mi QS, Meagher C, Delovitch TL: Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51:215-223, 2002
27. Fox CJ, Danska JS: Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 47:331-338, 1998
28. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A: Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 7:1057-1062, 2001
29. Solvason N, Wu WW, Kabra N, Wu X, Lees E, Howard MC: Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J Exp Med 184:407-417, 1996
30. Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE: Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J Exp Med 155:914-923, 1982
31. Rabin EM, Mond JJ, Ohara J, Paul WE: B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide. J Exp Med 164:517-531, 1986
32. Fu YX, Storb U: Immunology: autoreactive B cells migrate into T cell territory. Science 297:2006-2008, 2002
33. William J, Euler C, Christensen S, Shlomchik MJ: Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297:2066-2070, 2002
34. Arreaza G, Salojin K, Yang W, Zhang J, Gill B, Mi QS, Gao JX, Meagher C, Cameron M, Delovitch TL: Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin Immunol 107:103-115, 2003
35. Colucci F, Cilio CM, Lejon K, Goncalves CP, Bergman ML, Holmberg D: Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J Autoimmun 9:271-276, 1996
36. Hodgkin PD, Basten A: B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol 7:121-129, 1995
37. Hahne M, Renno T, Schroeter M, Irmler M, French L, Bornard T, MacDonald HR, Tschopp J: Activated B cells express functional Fas ligand. Eur J Immunol 26:721-724, 1996
38. Wurster AL, Rodgers VL, White MF, Rothstein TL, Grusby MJ: Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem 277:27169-27175, 2002
39. Tominaga Y, Nagata M, Yasuda H, Okamoto N, Arisawa K, Moriyama H, Miki M, Yokono K, Kasuga M: Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin Immunol Immunopathol 86:209-218, 1998
40. Scott DW, Grdina T, Shi Y: T cells commit suicide, but B cells are murdered! J Immunol 156:2352-2356, 1996
41. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST, Marshak-Rothstein A: Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163-165, 1995